PERSPECTA

News from every angle

← Back to headlines

Sandoz Licenses Three Biosimilar Drugs from Shanghai Henlius Biotech

Sandoz has announced a deal to license three biosimilar drugs from Shanghai Henlius Biotech, expanding its pharmaceutical portfolio.

17 Aug, 03:32 — 17 Aug, 03:32
PostShare

Sources

Showing 1 of 1 sources
ReutersVery High13d ago

Sandoz to license three biosimilar drugs from Shanghai Henlius Biotech - Reuters

Sandoz to license three biosimilar drugs from Shanghai Henlius Biotech  Reuters

Read full article →

Related Stories

Arrowhead Reports Positive Phase 3 Data for Plozasiran in Hypertriglyceridemia Trial

4h ago

Dutch Health Agency Warns of Lethal Trump-Shaped Ecstasy Pills

5h ago

Austria Reports Record Heat-Related Deaths in June and July

7h ago

Nigeria Urges Early Cancer Detection to Improve Treatment Outcomes

10h ago